InMed Pharmaceuticals INM
NASDAQ INM
$1.35 -0.01 (-0.74%)
At close: Oct 1, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Liabilities and Shareholders Equity (2020 - 2026)

Updated

InMed Pharmaceuticals (INM) recorded Liabilities and Shareholders Equity of $3.03 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 80.6% from $15.58 million a year earlier and down 66.8% from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Starting with fiscal Q4 2020, InMed Pharmaceuticals' Liabilities and Shareholders Equity history includes 25 quarters.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -20.9% (FY2021 to FY2026).
  • Across earlier fiscal years, Liabilities and Shareholders Equity came in at $15.58 million in FY2025 (+31.8%), $11.82 million in FY2024 (-16.2%), $14.11 million in FY2023 (+10.3%) and $12.79 million in FY2022 (+30.7%).
  • The fiscal Q4 2026 figure is the lowest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2020.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in three of the last eight quarters, with an average decline of 8.7%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 162.4% in fiscal Q1 2022, against a decline of 80.6% in fiscal Q4 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $9.13 million (Q3 2026), $11.19 million (Q2 2026) and $13.36 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Linde 218.80 Bn 201.92 Bn 4.43 Bn 88.35 Bn
2 Corning 132.43 Bn 125.56 Bn 1.63 Bn 32.96 Bn
3 Sherwin Williams 78.49 Bn 77.53 Bn 3.34 Bn 26.95 Bn
4 Air Products & Chemicals 61.97 Bn 59.87 Bn 1.04 Bn 40.45 Bn
5 Corteva 51.82 Bn 40.62 Bn 3.66 Bn 41.64 Bn
6 LyondellBasell Industries 37.12 Bn 26.74 Bn 2.04 Bn 34.48 Bn
7 Nutrien 33.86 Bn 30.73 Bn 3.25 Bn 53.56 Bn
8 Qnity Electronics 26.31 Bn 23.73 Bn 666.00 Mn 14.33 Bn
9 Ati 25.78 Bn 23.93 Bn 309.80 Mn 5.74 Bn
10 InMed Pharmaceuticals 5.66 Mn 3.46 Mn - 3.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.03 Mn
Mar 31, 2026 9.13 Mn
Dec 31, 2025 11.19 Mn
Sep 30, 2025 13.36 Mn
Jun 30, 2025 15.58 Mn
Mar 31, 2025 9.28 Mn
Dec 31, 2024 8.50 Mn
Sep 30, 2024 10.47 Mn
Jun 30, 2024 11.82 Mn
Mar 31, 2024 13.36 Mn
Dec 31, 2023 15.26 Mn
Sep 30, 2023 10.92 Mn
Jun 30, 2023 14.11 Mn
Mar 31, 2023 14.73 Mn
Dec 31, 2022 16.92 Mn
Sep 30, 2022 14.58 Mn
Jun 30, 2022 12.79 Mn
Mar 31, 2022 15.49 Mn
Dec 31, 2021 19.38 Mn
Sep 30, 2021 17.33 Mn
API Access

InMed Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INM&period=max&api_key=YOUR_API_KEY